Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying

The Dow Jones edged higher on Friday, recording gains for the tenth straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Virco Mfg. Corporation

• The Trade: Virco Mfg. Corporation VIRC Director Bradley C Richardson acquired a total of 1,770 shares an average price of $4.24. To acquire these shares, it cost around $7,505.
• What’s Happening: The company posted a narrower-than-expected first-quarter loss.
• What Virco Mfg. Does: Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets.

Anixa Biosciences

• The Trade: Anixa Biosciences, Inc. ANIX President, COO and CFO Michael Catelani acquired a total of 5,500 shares at an average price of $3.64. The insider spent around $20,020.
• What’s Happening: Anixa Biosciences announced issuance of Canadian Patent for its CAR-T cancer therapy technology.
• What Anixa Biosciences Does: Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer.

1847 Holdings

• The Trade: 1847 Holdings LLC EFSH 10% owner Strategic Risk LLC acquired a total of 72,327 shares at an average price of $0.19. To acquire these shares, it cost around $13,554.
• What’s Happening: 1847 sees revenue of $20 million for the second quarter, representing a 54% increase year over year.
• What 1847 Holdings Does: 1847 Holdings LLC is a diversified holding company. It operates in three segments: Retail and appliances, Construction, and Automotive Supplies.

Check This Out: Top 5 Financial Stocks That May Crash This Quarter

Don’t forget to check out our premarket coverage here